Navigation Links
Accuray Hosts Symposium on Quality Assurance in Radiation Oncology at Joint AAPM/COMP Meeting
Date:7/20/2011

SUNNYVALE, Calif., July 20, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, will host a symposium examining best practices for quality assurance in radiation oncology at the 2011 Joint American Association of Physicists in Medicine (AAPM)/Canadian Organization of Medical Physicists (COMP) Meeting. The symposium—"Best Quality Assurance Programs for Today's Radiation Oncology Platforms"—will discuss how systems' engineering principles can be applied to radiotherapy quality assurance (QA) and quality compliance (QC). The 2011 Joint AAPM/COMP Meeting takes place July 31-August 4, 2011 in Vancouver, British Columbia.WHO:Sonja Dieterich, Ph.D., DABR, Chief of Clinical Physics at Stanford University School of Medicine, and Sasa Mutic, Ph.D., Chief of Clinical Medical Physics and Associate Professor of Radiation Oncology at Washington University School of MedicineWHAT:A complimentary luncheon and discussion of best practices for QA in radiation oncology. The symposium will also discuss the protocols and recommendations of task group TG-135, which has been dedicated to setting QA standards in the field of robotic radiosurgery.WHEN:Monday, August 1, 201112:30 PM to 2:00 PM PDTWHERE:The 2011 Joint AAPM/COMP Meeting Fairmont Pacific RimSapphire Ballroom1038 Canada PlaceVancouver, British ColumbiaWHY:Precision radiosurgery and intensity-modulated radiotherapy require strict QA to ensure safe operation. This symposium will highlight QC measurements and QA procedures that can minimize adverse results related to Accuray's technologies including the CyberKnife® Robotic Radiosurgery System and the TomoTherapy® Radiation Therapy System.HOW: Attendees interested in participating in the symposium may register online.About AccurayAccuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. Accuray's game-changing technologies – the CyberKnife System and TomoTherapy System – set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company's technologies and more than 550 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869
Euan Thomson, Ph.D.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Accurays CyberKnife and TomoTherapy Systems Highlighted at World Conference on Lung Cancer
2. Accuray Hosts Korean Embassys Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement
3. Accuray Successfully Completes Acquisition of TomoTherapy
4. TomoTherapy Shareholders Approve Accuray Acquisition of TomoTherapy
5. Accuray Incorporateds CEO to Speak at Jefferies 2011 Global Healthcare Conference
6. Accuray Showcases CyberKnife Robotic Radiosurgery System at American Urological Association Meeting
7. Accuray Announces Results for Third Quarter of Fiscal 2011
8. Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
9. Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2011
10. Accuray Incorporated to Speak at 10th Annual Needham Healthcare Conference
11. Accuray to Acquire TomoTherapy for Approximately $277 Million in Cash and Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... -- A new survey from the American Association ... Program (CBP) significantly reduced beneficiary choice and access to ... forces beneficiaries to switch to unfamiliar or unsuitable testing ... AADE,s survey is the latest in a continuous ... the inherent problems with the CBP. Last year, a ...
(Date:3/27/2017)... YORK , March 27, 2017 FinancialBuzz.com ... Based ... adult use in states where cannabis is legal will generate $655 ... million will be from cannabis specific taxes, such as ... $96 million will be earned from state sales taxes that are ...
(Date:3/27/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... AGI-134, an immunotherapy for the treatment of multiple cancers, obtained ... featured at the upcoming American Association for Cancer Research ... to be held on April 1-5, 2017. ... An abstract titled ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... , ... The Case Management Society of America (CMSA) will install six new ... membership has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to serve on ... Advisory position has also been added to the BOD, per an appointment made by ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek ... to pursue the recent RNA methylation “gold rush” with their established portfolio of ... newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has received a ...
(Date:3/27/2017)... Foothill Ranch, California (PRWEB) , ... March 27, 2017 , ... ... company’s commitment to its customers. First National Capital has added 10 new sales professionals ... to grow its sales positions by 15 additional new hires over the course of ...
(Date:3/27/2017)... RICHEY, Fla. (PRWEB) , ... March 27, 2017 ... ... drug overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of ... Kevin McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce the ... subjects. The ELITE DXA has an active scan window, which is more than double ... fit in the scan area could not undergo an accurate total body bone density or ...
Breaking Medicine News(10 mins):